Pharmacological means of reducing estrogen via aromatase inhibitors has become a relatively new therapeutic option in the breast cancer.
Estrogens are known to be important in the growth of breast cancers in both pre- and postmenopausal women. As the number of breast cancer.
Aromatase inhibitors are medications that stop the production of estrogen in postmenopausal They are used to treat hormone-receptor-positive breast cancer.
Aromatase inhibitors (anastrozole, letrozole and exemestane) are hormone therapy drugs used to treat hormone receptor-positive breast cancer. Aromatase .
We examined published reports on the use of aromatase inhibitors in postmenopausal patients with hormone receptor-positive breast cancer. Our data were.